<i>BRCA2</i> , <i>ATM</i> , and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical AggressionEvan W. Warner, Alexander W. Wyatt, Elie Ritch et al.|Clinical Cancer Research|2021Cited by 87
Predictors of germline DNA damage repair gene mutations (gDDRm) in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).Steven Yip, Kim N., Katherine Sunderland et al.|Journal of Clinical Oncology|2019Cited by 1
Abstract PR09: Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutationsEvan W. Warner, Alexander W. Wyatt, Steven Yip et al.|Clinical Cancer Research|2020Cited by 1